Challenges in herbal research: A randomized clinical trial to assess blinding with ginger

Schulz, 1996, Blinding and exclusions after allocation in randomized controlled trials: survey of published parallel group trials in obstetrics and gynaecology, BMJ, 312, 742, 10.1136/bmj.312.7033.742

Schulz, 2002, The landscape and lexicon of blinding in randomized trials, Ann Intern Med, 136, 245, 10.7326/0003-4819-136-3-200202050-00022

Devereaux, 2001, Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials, JAMA, 285, 2000, 10.1001/jama.285.15.2000

Colditz, 1989, How study design affects outcomes in comparisons of therapy, Stat Med, 8, 441, 10.1002/sim.4780080408

Schulz, 1995, Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.273.5.408

Juni, 2001, Assessing the quality of controlled clinical trials, BMJ, 323, 42, 10.1136/bmj.323.7303.42

Arfeen, 1995, A double-blind randomized controlled trial of ginger for the prevention of postoperative nausea and vomiting, Anaesth Intensive Care, 23, 449, 10.1177/0310057X9502300406

Bone, 1990, Ginger root—a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynaecological surgery, Anaesthesia, 45, 669, 10.1111/j.1365-2044.1990.tb14395.x

Eberhart, 2003, Ginger does not prevent postoperative nausea and vomiting after laparoscopic surgery, Anesth Analg, 96, 995, 10.1213/01.ANE.0000055818.64084.41

Farrington, 1990, Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk, Stat Med, 9, 1447, 10.1002/sim.4780091208